Literature DB >> 16154686

Anti-tumor activity of a 3-oxo derivative of oleanolic acid.

Dan Huang1, Yan Ding, Yan Li, Wenming Zhang, Weishuo Fang, Xiaoguang Chen.   

Abstract

Oleanolic acid (3beta-hydroxy-olea-12-en-28-oic acid, OA) exists widely in plant kingdom and possesses various pharmacological activities. In recent years, it was found that it had marked anti-tumor effects and exhibited cytotoxic activity towards many cancer cell lines in culture. In this article, the anti-tumor and differentiation-inducing effects of a derivative of OA modified at C-3, 3-oxo oleanolic acid (3-oxo-olea-12-en-28-oic acid, 3-oxo-OA, 3-7-1) was reported. In vitro, 3-7-1 were found to inhibit significantly the growth of cancer cells derived from different tissues. And 3-7-1 had inhibitory effect on melanoma in vivo. This selection may relate to the differentiation induced by 3-7-1. The inhibition of 3-7-1 on B16-BL6 suggests that 3-7-1 may be a useful anti-cancer agent for melanoma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16154686     DOI: 10.1016/j.canlet.2005.03.019

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  12 in total

1.  Bioactive Compounds from Medicinal Plants in Myanmar.

Authors:  Nwet Nwet Win; Hiroyuki Morita
Journal:  Prog Chem Org Nat Prod       Date:  2021

2.  Biotransformation using Mucor rouxii for the production of oleanolic acid derivatives and their antimicrobial activity against oral pathogens.

Authors:  Clarissa S Capel; Ana C D de Souza; Tatiane C de Carvalho; João P B de Sousa; Sérgio R Ambrósio; Carlos H G Martins; Wilson R Cunha; Rosario H Galán; Niege A J C Furtado
Journal:  J Ind Microbiol Biotechnol       Date:  2011-01-13       Impact factor: 3.346

3.  Oleanolic acid derivative Dex-OA has potent anti-tumor and anti-metastatic activity on osteosarcoma cells in vitro and in vivo.

Authors:  Yingqi Hua; Zhiyu Zhang; Jianxin Li; Quan Li; Shuo Hu; Jian Li; Mengxiong Sun; Zhengdong Cai
Journal:  Invest New Drugs       Date:  2009-11-27       Impact factor: 3.850

4.  The dual induction of apoptosis and autophagy by SZC014, a synthetic oleanolic acid derivative, in gastric cancer cells via NF-κB pathway.

Authors:  Li Xiao Rui; Song Yu Shu; Wu Jing Jun; Chen Zi Mo; Sun Zheng Wu; Liu Shu Min; Lin Yuan; Peng Jin Yong; Song Zhi Cheng; Wang Shi Sheng; Tang Ze Yao
Journal:  Tumour Biol       Date:  2015-11-07

5.  Anticancer and apoptotic activities of oleanolic acid are mediated through cell cycle arrest and disruption of mitochondrial membrane potential in HepG2 human hepatocellular carcinoma cells.

Authors:  Yue-Yong Zhu; Hong-Yan Huang; Yin-Lian Wu
Journal:  Mol Med Rep       Date:  2015-07-02       Impact factor: 2.952

6.  Semisynthesis of Derivatives of Oleanolic Acid from Syzygium aromaticum and Their Antinociceptive and Anti-Inflammatory Properties.

Authors:  Sibusiso Rali; Opeoluwa O Oyedeji; Olukayode O Aremu; Adebola O Oyedeji; Benedicta N Nkeh-Chungag
Journal:  Mediators Inflamm       Date:  2016-06-13       Impact factor: 4.711

7.  Synthesis of acyl oleanolic acid-uracil conjugates and their anti-tumor activity.

Authors:  Wei-Bin Mo; Chun-Hua Su; Jia-Yan Huang; Jun Liu; Zhen-Feng Chen; Ke-Guang Cheng
Journal:  Chem Cent J       Date:  2016-11-21       Impact factor: 4.215

8.  The pseudoginsenoside F11 ameliorates cisplatin-induced nephrotoxicity without compromising its anti-tumor activity in vivo.

Authors:  Hongbo Wang; Liang Kong; Jianqiao Zhang; Guohua Yu; Guangyao Lv; Fangxi Zhang; Xiaoguang Chen; Jingwei Tian; Fenghua Fu
Journal:  Sci Rep       Date:  2014-05-16       Impact factor: 4.379

9.  The study of a novel sorafenib derivative HLC-080 as an antitumor agent.

Authors:  Ke Tang; Can Luo; Yan Li; Chenshu Lu; Wanqi Zhou; Haihong Huang; Xiaoguang Chen
Journal:  PLoS One       Date:  2014-07-08       Impact factor: 3.240

10.  Design and preparation of derivatives of oleanolic and glycyrrhetinic acids with cytotoxic properties.

Authors:  Rui Wang; Yang Li; Xu-Dong Huai; Qing-Xuan Zheng; Wei Wang; Hui-Jing Li; Qi-Yong Huai
Journal:  Drug Des Devel Ther       Date:  2018-05-21       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.